EVEscape utilizes a generative model of evolutionary sequences and incorporates detailed biological and structural data to predict mutations in viral proteins, anticipate emerging variants of SARS-CoV-2, and assess their potential impact on vaccines and therapies, aiding in proactive public health responses. Researchers tested EVEscape retrospectively on SARS-CoV-2 data and found the model effective in accurately predicting mutations from early-stage data.